KLK3 and prostate carcinoma: Uncontrolled proteolytic activities of KLKs are associated with disease states including cancer, inflammation, and neurodegeneration, and they are overexpressed in various malignancies; for example, KLK3 expression is currently used as a marker for prostate cancer.